health · HHS-NIH11
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-27-016
Award Range
$0 – $600K
Total Program Funding
$4.0M
Expected Awards
5
Deadline
July 10, 2026
GRANTQUICK SUMMARYPlain-English Overview
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed). National Institutes of Health. The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by... up to $600,000 per award; $4,000,000 total program funding; ~5 awards expected.
Who Should Apply
Nonprofits (501c3), Public And Indian Housing Authorities, Nonprofits (non-501c3), County governments, State governments (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Refer to Section III
- •Deadline: 2026-07-10
💡 GrantQuick Tip
High-value award — invest significantly in proposal quality. Consider hiring a grant writer.
Competitiveness: Very high — extremely limited awards available
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Maximum Award
- $600K
- Total Program Funding
- $4.0M
- Expected Number of Awards
- 5
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
National Institute of Allergy and Infectious Diseases (NIAID) TRACs Program NIAIDTRACS@mail.nih.gov
NIAIDTRACS@mail.nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov